A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines
Katherine R. Singleton(Duke University), Lynn E. Heasley(VA Eastern Colorado Health Care System)
Cited by 43
Related Papers
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
|Oncogenesis|2013|256
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
|Science Signaling|2014|199
Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
|PLoS ONE|2010|145